Wilmer Cutler Pickering Hale and Dorr advised Dyne Therapeutics, Inc. on the offering, and Cooley advised the underwriters. Dyne Therapeutics, Inc. (Nasdaq:DYN) announced the closing of...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Eliem Therapeutics on the deal, and Cooley advised Tenet Medicines. Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced that it had entered into...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Dyne Therapeutics, Inc., and Cooley advised the underwriters. Dyne Therapeutics, Inc. (Nasdaq:DYN) (“Dyne”) announced the closing of an underwritten public offering...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler advised Celldex Therapeutics, Inc. on the offering, and Wilmer Cutler Pickering Hale and Dorr advised the underwriters. Celldex Therapeutics, Inc. (Nasdaq: CLDX) (“Celldex”) announced the...
You must be a Standard 1 Year member to access this content.
